• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
TechEngage

TechEngage®

Technology Reviews, Guides & Analysis

  • Cryptocurrency
  • Science
    • Energy
    • Environment
    • Health
    • Space
  • Apps
  • More
    • Opinion
    • Noteworthy
    • Culture
    • Events
    • Deals
    • Startups
      • Startup Submissions
  • Videos
  • Tools
TechEngage » Science

Superbug genes found in the (formerly) last pristine place on Earth

Avatar for Jessica Baron, PhD Jessica Baron, PhD Follow Jessica Baron, PhD on Twitter February 3, 2019

Shares6FacebookTweetPinLinkedInPrintEmail

Well, so much for the idea of a place on Earth untouched by bad human decisions.

Antibiotic-resistant genes (ARGs), the result of overzealous prescription of antibiotics by doctors that lead to drug-resistant infections, have been found in the High Arctic, specifically the Kongsfjorden region of Svalbard.

Soil samples taken from the area have confirmed the presence of the blaNDM-1 gene, which was originally identified in 2008 in Delhi and two years later in the surface waters of the region. The blaNDM-1, as well as other ARGs, can now be found in Arctic soils, according to researchers from Newcastle University. The researchers say they were likely brought there by birds, other wildlife, and human visitors to the area and deposited into the soil via the fecal matter of these visitors.

The lead researcher on the study, Professor David Graham noted that polar regions like Kongsfjorden “are among the last presumed pristine ecosystems on Earth,” and

“Encroachment into areas like the Arctic reinforces how rapid and far-reaching the spread of antibiotic resistance has become, confirming solutions to AR must be viewed in global rather than just local terms.”

This discovery adds more fuel to the growing public health crisis posed by antibiotic-resistant infections. Drug development and testing simply can’t keep up with ever-evolving diseases. And while we’ve long known the role of overprescribing antibiotics in creating new and hard-to-treat infections, this hasn’t stopped patients from demanding (and doctors from prescribing) antibiotics in inappropriate ways.

The Newcastle study was designed to track a specific protein the confers resistance on a range of bacteria called NDM-1. It was first identified in New Delhi and is coded by the blaNDM-1 gene. Since its original identification ins 2008, the resistant gene has been found in over 100 countries and new variants continue to pop up, making a solution even more elusive.

Currently, the last resort for multidrug-resistant infections is a class of drug called Carbapenems. There are very few antibiotics that can combat bacteria resistant to Carbapenems, so the spread of  blaNDM-1 and related ARGs is a huge public health conundrum.

According to Graham,

“What humans have done through excess use of antibiotics on global scales is accelerate the rate of evolution, creating a new world of resistant strains that never existed before.

Through the overuse of antibiotics, fecal releases and contamination of drinking water, we have consequentially speeded-up the rate at which superbugs might evolve.”

Good job, humanity.

Another member of the team, Dr. Clare McCann, of Newcastle University noted that:

“The only way we are going to win this fight is to understand all pathways that lead to antibiotic resistance.

Clearly, improved antibiotic stewardship in medicine and agriculture is crucial, but understanding how resistance transmission occurs through water and soils is also critical. We contend that improved waste management and water quality on a global scale is a key step.”

Filed Under: Science, Environment, Health Tagged With: ARGs, Discovery, Scientific Research

Related Stories

  • The Trend Of Medical Apps And Websites

    The Trend of Medical Apps and Websites

  • Role Of Tech Companies In Improving Healthcare

    Role of Tech Companies in improving healthcare

  • Artificial Intelligence In Healthcare

    Artificial intelligence in healthcare

Shares6FacebookTweetPinLinkedInPrintEmail
Avatar for Jessica Baron, PhD

Jessica Baron, PhD

Science & Health Tech Correspondent

Dr. Jessica Baron is a Science and Health Tech Correspondent at TechEngage. She holds a PhD in History and Philosophy of Science and writes about health technology, cybersecurity, robotics, and artificial intelligence. Her work has appeared in international news and trade outlets, and she brings academic rigor and ethical perspective to every piece she publishes.

Joined December 2018

Reader Interactions

Share Your Thoughts Cancel reply

Please read our comment policy before submitting your comment. Your email address will not be used or published anywhere. You will only receive comment notifications if you opt to subscribe below.

Primary Sidebar

TechEngage-Apple-News TechEngage-Google-News

Recent Stories

  • The Complete History of the Internet: From ARPANET to AI (Visual Timeline)
  • The 10 Best-Selling Cars of All Time [Infographic]
  • Best Gaming Graphics Cards (GPUs): 8 Picks From Budget to Enthusiast
  • Best Long-Range Outdoor WiFi Extenders: 8 Tested Picks for Reliable Coverage
  • Best AM Radios for Long-Distance Reception: 10 Tested Picks

Footer

Discover

  • About TechEngage
  • Newsroom
  • Our Team
  • Advertise
  • Send us a tip
  • Startup Submission Questionnaire
  • Brand Kit
  • Contact us

Legal pages

  • Reviews Guarantee & Methodology
  • Community Guidelines
  • Corrections Policy and Practice
  • Cookies Policy
  • Our Ethics
  • Disclaimer
  • GDPR Compliance
  • Privacy Policy
  • Terms and Conditions

Must reads

  • Best AirPods alternatives on Amazon
  • Best PC monitors for gaming on Amazon
  • Best family board games
  • Best video doorbells without subscription
  • Best handheld video game consoles
  • Best all-season tires for snow
  • Best mobile Wi-Fi hotspots
  • Best treadmills on Amazon

Download our apps

TechEngage app coming soon on App Store

© 2026 TechEngage®. All Rights Reserved. TechEngage® is a project of TechAbout LLC.

TechEngage® is a registered trademark in the United States under Trademark Number 6823709 and in the United Kingdom under Trademark Number UK00003417167. It is also ISSN protected under ISSN 2690-3776 and has OCLC Number 1139335774.